National Institute for Health and Clinical Excellence (NICE) - A to Z
This page contains links to content about the National Institute for Health and Clinical Excellence (NICE).
NICE is an independent organisation that decides which drugs and treatments are available on the NHS in England and Wales.
Or find out more using the links below.
Related categories
National Institute for Health and Clinical Excellence (NICE) is a sub-category of Policy and Drug regulation and approval
Browse content about National Institute for Health and Clinical Excellence (NICE)
- News story: Clarity over Cancer Drugs Fund should be 'a priority'
4 April 2013 - News story: NICE recommends new treatments for advanced melanoma
2 November 2012 - Press Release: Cancer Research UK welcomes prostate cancer drug approval in Wales
20 February 2012 - News story: Some health trusts 'banning costly cancer drugs', says investigation
24 November 2011 - News story: NICE recommends bortezomib and thalidomide for multiple myeloma
26 August 2010 - News story: NICE guideline focuses on care for patients with cancer of unknown primary
27 July 2010 - News story: NICE updates skin cancer guidance
2 June 2010 - News story: NICE rejects drug for rare pre-cancerous conditions
5 March 2010 - News story: NICE rules against liver cancer drug sorafenib
19 November 2009 - News story: NICE rejects life-extending breast cancer drug lapatinib
23 October 2009
- News story: MPs criticise lack of clarity on new drug pricing system
16 January 2013 - News story: NICE recommends new targeted lung cancer treatment
10 May 2012 - Press Release: Prostate cancer NICE decision 'makes no sense'
2 February 2012 - News story: NICE recommends azacitidine for myelodysplastic syndromes
24 March 2011 - News story: NICE draft guidance rejects bevacizumab for advanced bowel cancer
24 August 2010 - News story: NICE recommends minimum alcohol pricing
3 June 2010 - News story: People with rarer cancers 'still denied access to treatments'
17 March 2010 - News story: NICE agrees cost-reducing scheme for new cancer drug trabectedin
22 December 2009 - News story: NICE recommends topotecan for cervical cancer
29 October 2009 - News story: NICE approves rituximab for chronic lymphocytic leukaemia
24 July 2009






Read press release
